If 2020 was a year of reckoning, 2021 was a year of action—and major milestones for The Cancer Letter and the cancer community.
In 1974, The Cancer Letter published a story listing seven proposed “laws” postulated by of one of oncology’s wise men, Emil J Freireich (The Cancer Letter, May 14, 1976).
In 1999, NCI recorded an oral history with Paul Marks, president and chief executive officer of Memorial Sloan Kettering Cancer Center from 1980-1999. Marks died April 28, 2021, at the age of 93.
On Jan. 3, 2022, a few weeks shy of her 101st birthday, my friend, colleague, and mentor Beatrice Mintz passed away after a long illness. Following a brief period at the University of Chicago, at age 40 she joined the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia. She went on […]
In celebration of the 50th anniversary of the National Cancer Act, President Biden thanked “the limitless ingenuity of the world’s finest nurses, physicians, and researchers.” Few better exemplify this ingenuity than Fox Chase’s Beatrice Mintz, whose obituary is published in this week’s issue. The Cancer History Project commemorates both this anniversary and the legacy of Beatrice Mintz.
After having treated over 200,000 COVID cases over two years—more than any health system in the U.S.—Northwell Health once again finds itself in the center of the storm as cases of the omicron variant escalate in New York State.
After consulting with women in oncology, The Cancer Letter has created a guide to help whistleblowers think strategically as they report gender bias and confront institutional resistance.
Forty-nine years and a few days after the signing of the National Cancer Act of 1971, we launched the Cancer History Project. One year and 11,894 articles later, we have built a shared, collaborative, and unprecedented resource.
Fifty years ago, President Nixon interrupted Christmas festivities to sign the National Cancer Act of 1971 into law. Fifty years later, we invite you to immerse yourself in that day to reflect on how far we’ve come.
Hal E. Broxmeyer, PhD, lost the final round of his battle with thyroid cancer on Dec. 8. Hal was our father, he was our brother, he was our mentor, and he was our friend. His was a life of impact.
